Story perspectives

Cigna Ends GLP-1 Coverage; Majority Employers Expect 2027 Coverage

6/15/2026

22 4

Summary

Cigna Cuts Coverage

Cigna will stop covering GLP-1 drugs in July 2026, prompting 10 % of employers to plan ending coverage by 2027.
A Business Group on Health survey indicates 72 % of firms expect to cover weight-loss treatments in 2027.
President and CEO Ellen Kelsay said employers fear the drugs’ cost amid rising health-care expenses.
Employers use Vida Health and Omada Health to manage spending, with Omada reporting 51 % growth while aiming to curb costs.

Summary

David Davis Step-Therapy

Step-therapy forces David Davis to try naltrexone and bupropion before Zepbound, though neither treats his sleep apnea.
Catherine Varney of UVA Health says telehealth pushes patients off drugs, noting a BMJ review of 37 studies (9,341 patients) shows stopping GLP-1 therapy leads to swift weight regain.
Medical ethicists warn that delays can worsen cardiovascular disease and joint damage, while East African insurers watch U.S. telehealth gatekeeper model as cost-containment template.

1 of 2

Cigna Cuts Coverage

Cigna will stop covering GLP-1 drugs in July 2026, prompting 10 % of employers to plan ending coverage by 2027.
A Business Group on Health survey indicates 72 % of firms expect to cover weight-loss treatments in 2027.
President and CEO Ellen Kelsay said employers fear the drugs’ cost amid rising health-care expenses.
Employers use Vida Health and Omada Health to manage spending, with Omada reporting 51 % growth while aiming to curb costs.

1 / 2